EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52003XC0603(04)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 April 2003 to 15 May 2003 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 April 2003 to 15 May 2003 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 April 2003 to 15 May 2003 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
OJ C 129, 3.6.2003, p. 22–35
(ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
52003XC0603(04)
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 April 2003 to 15 May 2003 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
Official Journal C 129 , 03/06/2003 P. 0022 - 0035
Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 April 2003 to 15 May 2003 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC(1) or Article 38 of Directive 2001/82/EC(2)) (2003/C 129/06) - Issuing, maintenance or modification of a national marketing authorisation >TABLE> - Suspension of a national marketing authorisation >TABLE> (1) OJ L 311, 28.11.2001, p. 67. (2) OJ L 311, 28.11.2001, p. 1. ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS, PACKAGING AND PACKAGE SIZES OF THE MEDICINAL PRODUCT IN THE MEMBER STATES FLUOXETINE-CONTAINING MEDICINAL PRODUCTS - ELI LILLY MARKETING AUTHORISATIONS IN THE EUROPEAN UNION >TABLE> ANNEX II LIST OF THE PHARMACEUTICAL FORMS, STRENGTHS, ROUTES OF ADMINISTRATION, PACKAGING AND PACKAGE SIZES OF THE VETERINARY MEDICINAL PRODUCT IN THE MEMBER STATES Marketing Authorisation Holder (Name and address): Reference Member State: UNITED KINGDOM Schering-Plough Ltd Schering-Plough House Shire Park Welwyn Garden City Herts AL7 1TW United Kingdom Concerned Member States: AUSTRIA Essex Tierarznei Ndl. der Essex Pharma GmbH Thomas-Dehler-Str. 27 D - 81737 München BELGIUM Schering-Plough NV/SA Rue de Stallesstraat 73 B - 1180 Brussels DENMARK Schering-Plough A/S Hvedemarken 12 DK - 3520 Farum FINLAND Schering-Plough A/S Hvedemarken 12 DK - 3520 Farum FRANCE Schering-Plough Veterinaire 92, rue Baudin F - 92300 Levallois-Perret GERMANY Essex Tierarznei Ndl. der Essex Pharma GmbH Thomas-Dehler-Str. 27 D - 81737 München GREECE Schering-Plough SA 63, Agiou Dimitriou Str. G - 17455 Alimos Athens IRELAND Schering-Plough Ltd Schering-Plough House Shire Park Welwyn Garden City Herts AL7 1TW United Kingdom LUXEMBOURG Schering-Plough NV/SA Rue de Stallesstraat 73 B - 1180 Brussels PORTUGAL Schering-Plough II-Veterinaria, Lda Casal Colaride, Agualva P - 2735 Cacem SPAIN Schering-Plough SA Km 36, Carretera Nacional I E - 28750 San Agustin de Guadalix Madrid SWEDEN Schering-Plough A/S Hvedemarken 12 DK - 3520 Farum THE NETHERLANDS Schering-Plough NV/SA Rue de Stallesstraat 73 B - 1180 Brussels Presentations: >TABLE> ANNEX III LIST OF NAMES OF THE VETERINARY MEDICINAL PRODUCTS BASED ON BENZATHINE PENICILLIN FOR FOOD PRODUCING ANIMALS AND MARKETING AUTHORISATION HOLDERS IN EU MEMBER STATES, ICELAND AND NORWAY >TABLE>